Analysts expect Climb Bio, Inc. to report revenue of 0.00 for Q3 26, against a range of 0.00 to 0.00. The most recent reported quarter, Q2 26, came in at 0.00.
| Metric | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | Q3 26 | Q4 26 | Q1 27 | Q2 27 | Q3 27 | Q4 27 | Q1 28 | Q2 28 | Q3 28 | Q4 28 | Q1 29 | Q2 29 | Q3 29 | Q4 29 | Q1 30 | Q2 30 | Q3 30 | Q4 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | - | - | - | - | - | - | - | - | ||||||||||
| High Estimate | - | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 84,763.23 | 120,942.80 | 253,408.28 | 241,057.22 | ||||||||||
| Low Estimate | - | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 71,918.17 | 101,888.50 | 226,370.36 | 206,101.06 | ||||||||||
| Consensus Estimate | - | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 78,340.70 | 111,415.65 | 239,889.32 | 223,579.14 |
Analysts expect Climb Bio, Inc. to report earnings per share of -0.19 for Q3 26, against a range of -0.21 to -0.17. The most recent reported quarter, Q2 26, came in at -0.18, a 18.2% beat against the -0.22 consensus.
| Metric | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | Q3 26 | Q4 26 | Q1 27 | Q2 27 | Q3 27 | Q4 27 | Q1 28 | Q2 28 | Q3 28 | Q4 28 | Q1 29 | Q2 29 | Q3 29 | Q4 29 | Q1 30 | Q2 30 | Q3 30 | Q4 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | -0.13 | -0.13 | -0.31 | -0.13 | -0.19 | -0.26 | -0.20 | -0.18 | - | - | - | - | - | - | - | - | ||||||||||
| High Estimate | - | -0.15 | -0.14 | -0.18 | -0.14 | -0.19 | -0.25 | -0.21 | -0.17 | -0.21 | -0.20 | -0.23 | -0.23 | -0.26 | -0.33 | -0.28 | ||||||||||
| Low Estimate | - | -0.17 | -0.16 | -0.20 | -0.16 | -0.23 | -0.31 | -0.23 | -0.21 | -0.23 | -0.24 | -0.27 | -0.27 | -0.30 | -0.35 | -0.32 | ||||||||||
| Consensus Estimate | - | -0.16 | -0.15 | -0.19 | -0.15 | -0.21 | -0.28 | -0.22 | -0.19 | -0.22 | -0.22 | -0.25 | -0.25 | -0.28 | -0.34 | -0.30 |
Pull Wall Street consensus for Climb Bio, Inc. (high, low and consensus estimates alongside reported actuals) into your own models and apps with the Business Quant Estimates API. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/estimates?ticker=CLYM&mode=revenue&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/estimates"
params = {"ticker": "CLYM", "mode": "revenue", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/estimates?ticker=CLYM&mode=revenue&api_key=YOUR_API_KEY");
const data = await res.json();